Q&A: Bernard Munos

Eric Bender

Nature, 2016, vol. 533, issue 7602, S59-S59

Abstract: In 2006, pharmaceutical innovation consultant Bernard Munos helped to launch a lively public discussion about how open innovation can bring novel drugs to market with his paper 'Can opensource R&D reinvigorate drug research? He tells Nature how things have changed since then.

Date: 2016
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/533S59a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:533:y:2016:i:7602:d:10.1038_533s59a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/533S59a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().